Bridging the gap between autoinflammation and autoimmunity

Clinical Immunology

Volumn 147, Issue 3, 2013, Pages 151-154

  Hedrich, Christian M ^a   Tsokos, George C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CALGRANULIN A; CASPASE RECRUITMENT DOMAIN PROTEIN 15; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; PROTEIN S 100; S100A12 PROTEIN; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; INFLAMMASOME;

ADAPTIVE IMMUNITY; AUTOIMMUNITY; AUTOINFLAMMATORY DISEASE; B LYMPHOCYTE; CELL DIFFERENTIATION; CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS; CINCA SYNDROME; CROHN DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EDITORIAL; FAMILIAL MEDITERRANEAN FEVER; GENE MUTATION; HUMAN; INFLAMMATORY BOWEL DISEASE; INNATE IMMUNITY; JUVENILE RHEUMATOID ARTHRITIS; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MEVALONATE KINASE DEFICIENCY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEIC ACID METABOLISM; OSTEOMYELITIS; PATHOGENESIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; TH17 CELL; TH2 CELL; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME; ULCERATIVE COLITIS; UPREGULATION; GENETIC PREDISPOSITION; GENETICS; HEREDITARY PERIODIC FEVER; IMMUNOLOGY;

AUTOIMMUNITY; GENETIC PREDISPOSITION TO DISEASE; HEREDITARY AUTOINFLAMMATORY DISEASES; HUMANS; INFLAMMASOMES;

EID: 84882276010     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2013.03.006     Document Type: Editorial

References (28)

1. M.F. McDermott, I. Aksentijevich, J. Galon, E.M. McDermott, B.W. Ogunkolade, M. Centola, E. Mansfield, M. Gadina, L. Karenko, T. Pettersson, et al., Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes, Cell 97 (1999) 133-144.
2. R. Goldbach-Mansky, D.L. Kastner, Autoinflammation: the prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses, J. Allergy Clin. Immunol. 124 (2009) 1141-1149.
3. D.L. Kastner, I. Aksentijevich, R. Goldbach-Mansky, Autoinflammatory disease reloaded: a clinical perspective, Cell 140 (2010) 784-790.
4. S.L. Masters, A.A. Lobito, J. Chae, D.L. Kastner, Recent advances in the molecular pathogenesis of hereditary recurrent fevers, Curr. Opin. Allergy Clin. Immunol. 6 (2006) 428-433.
5. S.R. Hofmann, H. Morbach, T. Schwarz, A. Rosen-Wolff, H.J. Girschick, C.M. Hedrich, Attenuated TLR4/MAPK signaling in monocytes from patients with CRMO results in impaired IL-10 expression, Clin. Immunol. 145 (2012) 69-76.
6. S.R. Hofmann, A. Rosen-Wolff, G.C. Tsokos, C.M. Hedrich, Biological properties and regulation of IL-10 related cytokines and their contribution to autoimmune disease and tissue injury, Clin. Immunol. 143 (2012) 116-127.
7. S.L. Masters, Specific inflammasomes in complex diseases, Clin. Immunol. (2012).
8. H. Morbach, C.M. Hedrich, M. Beer, H.J. Girschick, Autoinflammatory bone disorders, Clin. Immunol. (2013).
9. L.E. Munoz, K. Lauber, M. Schiller, A.A. Manfredi, M. Herrmann, The role of defective clearance of apoptotic cells in systemic autoimmunity, Nat. Rev. Rheumatol. 6 (2010) 280-289.
10. P.J. Shaw, M.F. McDermott, T.D. Kanneganti, Inflammasomes and autoimmunity, Trends Mol. Med. 17 (2011) 57-64.
11. D. McGonagle, A. Aziz, L.J. Dickie,M.F. McDermott, An integrated classification of pediatric inflammatory diseases, based on the concepts of autoinflammation and the immunological disease continuum, Pediatr. Res. 65 (2009) 38R-45R.
12. A. Almeida de Jesus, R. Golbach-Mansky, Monogenic autoinflammatory diseases: Concept and clinical manifestations, Clin. Immunol. 147 (2013) 155-174.
13. M. Moll, J.B. Kuemmerle-Deschner, Inflammasomes and cytokine blocking strategies in autoinflammatory disorders, Clin. Immunol. 147 (2013) 242-275.
14. C.M. Hedrich, B. Fiebig, S. Sallmann, N. Bruck, G. Hahn, J. Roesler, A. Roesen-Wolff, G. Heubner, M. Gahr, Good response to IL-1beta blockade by anakinra in a 23-year-old CINCA/NOMID patient without mutations in the CIAS1 gene. Cytokine profiles and functional studies, Scand. J. Rheumatol. 37 (2008) 385-389.
15. C.M. Hedrich, N. Bruck, D. Paul, G. Hahn, M. Gahr, A. Rosen-Wolff, "Mutation negative" familial cold autoinflammatory syndrome (FCAS) in an 8-year-old boy: clinical course and functional studies, Rheumatol. Int. 32 (2012) 2629-2636.
16. B.R. van der, N.M. Ter Haar, M.L. Boes, J. Frenkel, Mevalonate kinase deficiency, a metabolic autoinflammatory disease, Clin. Immunol. (2012).
17. S.R. Hofmann, A. Roesen-Wolff, G. Hahn, C.M. Hedrich, Update: cytokine dysregulation in chronic nonbacterial osteomyelitis (CNO), Int. J. Rheumatol. 2012 (2012) 310206.
18. A. Doria, M. Zen, S. Bettio, M. Gatto, N. Bassi, L. Nalotto, A. Ghirardello, L. Iaccarino, L. Punzi, Autoinflammation and autoimmunity: bridging the divide, Autoimmun. Rev. 12 (2012) 22-30.
19. J.C. Moller, D. Paul, G. Ganser, U. Range, M. Gahr, R. Kelsch, A. Rosen-Wolff, C.M. Hedrich, IL10 promoter polymorphisms are associated with systemic onset juvenile idiopathic arthritis (SoJIA), Clin. Exp. Rheumatol. 28 (2010) 912-918.
20. S.R. Hofmann, T. Schwarz, J.C. Moller, H. Morbach, A. Schnabel, A. Rosen-Wolff, H.J. Girschick, C.M. Hedrich, Chronic nonbacterial osteomyelitis is associated with impaired Sp1 signaling, reduced IL10 promoter phosphorylation, and reduced myeloid IL-10 expression, Clin. Immunol. 141 (2011) 317-327.
21. C. Kessel, D. Holzinger, D. Foell, Phagocyte-derived S100 proteins in autoinflammation: putative role in pathogenesis and usefulness as biomarkers, Clin. Immunol. (2012).
22. M.C. Heymann, A. Rosen-Wolff, Contribution of the inflammasomes to autoinflammatory diseases and recent mouse models as research tools, Clin. Immunol. (2013).
23. M. Aringer, C. Gunther, M.A. Lee-Kirsch, Innate immune processes in lupus erythematosus, Clin. Immunol. (2012).
24. E. Segura, M. Touzot, A. Bohineust, A. Cappuccio, G. Chiocchia, A. Hosmalin, M. Dalod, V. Soumelis, S. Amigorena, Human inflammatory dendritic cells induce th17 cell differentiation, Immunity 38 (2013) 336-348.
25. A. Ablasser, C. Hertrich, R. Wassermann, V. Hornung, Nucleic acid driven sterile inflammation, Clin. Immunol. (2013).
26. A. Ablasser, V. Hornung, DNA sensing unchained, Cell Res. (2013).
27. D. Chowdhury, P.J. Beresford, P. Zhu, D. Zhang, J.S. Sung, B. Demple, F.W. Perrino, J. Lieberman, The exonuclease TREX1 is in the SET complex and acts in concert with NM23-H1 to degrade DNA during granzyme A-mediated cell death, Mol. Cell 23 (2006) 133-142.
28. M.A. Lee-Kirsch, M. Gong, D. Chowdhury, L. Senenko, K. Engel, Y.A. Lee, S.U. de, S.L. Bailey, T. Witte, T.J. Vyse, et al., Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus, Nat. Genet. 39 (2007) 1065-1067.